News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,297 Results
Type
Article (43760)
Company Profile (313)
Press Release (691211)
Multimedia
Podcasts (87)
Webinars (19)
Section
Business (208419)
Career Advice (2099)
Deals (35969)
Drug Delivery (113)
Drug Development (82489)
Employer Resources (174)
FDA (16540)
Job Trends (15178)
News (351808)
Policy (33080)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2657)
Academic (1)
Accelerated approval (32)
Adcomms (25)
Allergies (137)
Alliances (51103)
ALS (171)
Alzheimer's disease (1683)
Antibody-drug conjugate (ADC) (312)
Approvals (16795)
Artificial intelligence (545)
Autoimmune disease (145)
Automation (37)
Bankruptcy (365)
Best Places to Work (11780)
BIOSECURE Act (21)
Biosimilars (188)
Biotechnology (208)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (639)
Cancer (4813)
Cardiovascular disease (401)
Career advice (1776)
Career pathing (36)
CAR-T (277)
CDC (46)
Celiac Disease (2)
Cell therapy (736)
Cervical cancer (36)
Clinical research (70280)
Collaboration (1730)
Company closure (4)
Compensation (1149)
Complete response letters (54)
COVID-19 (2741)
CRISPR (91)
C-suite (841)
Cystic fibrosis (145)
Data (6208)
Decentralized trials (2)
Denatured (29)
Depression (133)
Diabetes (505)
Diagnostics (6766)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (263)
Drug pricing (190)
Drug shortages (28)
Duchenne muscular dystrophy (227)
Earnings (90887)
Editorial (58)
Employer branding (21)
Employer resources (152)
Events (119833)
Executive appointments (984)
FDA (19636)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1482)
Gene editing (196)
Generative AI (45)
Gene therapy (590)
GLP-1 (981)
Government (4723)
Grass and pollen (6)
Guidances (383)
Healthcare (19143)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (251)
Immuno-oncology (54)
Indications (104)
Infectious disease (3002)
Inflammatory bowel disease (190)
Inflation Reduction Act (14)
Influenza (112)
Intellectual property (246)
Interviews (330)
IPO (16811)
IRA (50)
Job creations (3749)
Job search strategy (1487)
JPM (58)
Kidney cancer (15)
Labor market (83)
Layoffs (566)
Leadership (30)
Legal (8036)
Liver cancer (91)
Longevity (14)
Lung cancer (643)
Lymphoma (373)
Machine learning (45)
Management (60)
Manufacturing (784)
MASH (162)
Medical device (13861)
Medtech (13914)
Mergers & acquisitions (20213)
Metabolic disorders (1271)
Multiple sclerosis (157)
NASH (16)
Neurodegenerative disease (315)
Neuropsychiatric disorders (87)
Neuroscience (2914)
Neurotech (1)
NextGen: Class of 2026 (6712)
Non-profit (4610)
Now hiring (65)
Obesity (594)
Opinion (269)
Ovarian cancer (165)
Pain (202)
Pancreatic cancer (223)
Parkinson's disease (287)
Partnered (34)
Patents (491)
Patient recruitment (482)
Peanut (55)
People (59923)
Pharmaceutical (65)
Pharmacy benefit managers (32)
Phase 1 (22024)
Phase 2 (30970)
Phase 3 (22950)
Pipeline (5134)
Policy (290)
Postmarket research (2573)
Preclinical (9431)
Press Release (69)
Prostate cancer (237)
Psychedelics (47)
Radiopharmaceuticals (283)
Rare diseases (839)
Real estate (6088)
Recruiting (69)
Regulatory (24666)
Reports (51)
Research institute (2473)
Resumes & cover letters (357)
Rett syndrome (27)
RNA editing (17)
RSV (76)
Schizophrenia (148)
Series A (245)
Series B (188)
Service/supplier (12)
Sickle cell disease (96)
Special edition (23)
Spinal muscular atrophy (159)
Sponsored (43)
Startups (3738)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (86)
The Weekly (56)
Vaccines (998)
Venture capital (86)
Weight loss (383)
Women's health (87)
Worklife (19)
Date
Today (27)
Last 7 days (599)
Last 30 days (2008)
Last 365 days (30375)
2026 (2903)
2025 (30809)
2024 (35880)
2023 (40675)
2022 (51800)
2021 (56347)
2020 (54745)
2019 (47335)
2018 (35592)
2017 (32952)
2016 (32282)
2015 (38223)
2014 (31983)
2013 (27100)
2012 (29255)
2011 (29939)
2010 (27955)
Location
Africa (775)
Alabama (85)
Alaska (7)
Arizona (308)
Arkansas (13)
Asia (40556)
Australia (6636)
California (11305)
Canada (3271)
China (1111)
Colorado (478)
Connecticut (489)
Delaware (334)
Europe (87936)
Florida (1670)
Georgia (357)
Hawaii (3)
Idaho (62)
Illinois (877)
India (63)
Indiana (519)
Iowa (23)
Japan (422)
Kansas (127)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1403)
Massachusetts (8192)
Michigan (320)
Minnesota (639)
Mississippi (5)
Missouri (135)
Montana (34)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (3044)
New Mexico (30)
New York (2973)
North Carolina (1482)
North Dakota (9)
Northern California (5494)
Ohio (329)
Oklahoma (21)
Oregon (41)
Pennsylvania (2274)
Puerto Rico (22)
Rhode Island (47)
South America (1154)
South Carolina (65)
South Dakota (1)
Southern California (4406)
Tennessee (173)
Texas (1742)
United States (40265)
Utah (339)
Vermont (1)
Virginia (265)
Washington D.C. (82)
Washington State (924)
West Virginia (4)
Wisconsin (119)
Wyoming (2)
735,297 Results for "x rx discovery inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MedImpact Completes Acquisition of Sav-Rx
February 3, 2026
·
2 min read
Press Releases
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use
January 29, 2026
·
5 min read
Press Releases
BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)
January 12, 2026
·
6 min read
Press Releases
Genvor, Inc. to Present at the 3rd Annual DealFlow Discovery Conference
January 20, 2026
·
1 min read
Press Releases
ABS Bio, Inc. acquires Cureline, Inc. to strengthen support of biopharma drug discovery
January 7, 2026
·
1 min read
Press Releases
Wellgistics Health Enters into LOI to Acquire Kare Rx Hub
November 4, 2025
·
1 min read
Press Releases
RIS Rx Appoints John Driscoll as Chairman of the Board
October 16, 2025
·
2 min read
Press Releases
Revium Rx Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections
October 22, 2025
·
5 min read
Press Releases
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
February 5, 2026
·
9 min read
Press Releases
Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage retinoid X nuclear receptor (RXR) agonist compound, for synergistically promoting killing of HER2+ breast cancer cells in combination with HER2-targeted chimeric antigen receptor modified T-cells (CAR-T).
December 12, 2025
·
3 min read
1 of 73,530
Next
